Haleon sees higher sales in 2024 as FY profits come in flat
Haleon
363.30p
16:45 08/11/24
0.44%
1.60p
Consumer health firm Haleon on Thursday posted flat annual earnings and said it expected to grow revenue this year on higher demand.
FTSE 100
8,072.39
17:14 08/11/24
n/a
n/a
FTSE 350
4,459.45
16:59 08/11/24
n/a
n/a
FTSE All-Share
4,417.83
16:44 08/11/24
n/a
n/a
Pharmaceuticals & Biotechnology
19,418.41
16:59 08/11/24
1.22%
233.86
The maker of Panadol pain relief, spun out of pharma giant GSK in 2022, posted pre-tax profits of £1.62bn for 2023, up 0.6%. It now expects revenue to rise 4% - 6% this year.
Revenue grew 4.1% to £11.3bn.
Reporting by Frank Prenesti for Sharecast.com